Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Astrazeneca Ord Shs AZNCF

Healthcare
AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory and immunology. Its pipeline forms a portfolio of investigational therapies in various stages of clinical development and... see more

Recent & Breaking News (OTCPK:AZNCF)

A Biotech Binary Event Playbook: How To Play Clovis And Tesaro Ahead Of Label Decision

Benzinga.com  August 8, 2017

Acalabrutinib Granted Breakthrough Therapy Designation by US FDA for the Treatment of Patients with Mantle Cell Lymphoma

Business Wire August 1, 2017

IMFINZI™ (durvalumab) Granted Breakthrough Therapy Designation by US FDA for Patients with Locally Advanced Unresectable Non-Small Cell Lung Cancer

Business Wire July 31, 2017

Why Is AstraZeneca Sinking Today?

Benzinga.com  July 27, 2017

20 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  July 27, 2017

TAGRISSO® (osimertinib) Significantly Improves Progression-Free Survival in the Phase III FLAURA Trial for Lung Cancer

Business Wire July 27, 2017

Valeant Announces U.S. Launch of SILIQ™ (brodalumab) Injection

PR Newswire July 27, 2017

The Market In 5 Minutes

Benzinga.com  July 14, 2017

Analyst Wonders If AstraZeneca's CEO Would Be A Fit At Teva

Benzinga.com  July 13, 2017

Breakfast Technical Briefing on Drug Makers Stocks -- Bristol Myers Squibb, Eli Lilly, AstraZeneca, and Sanofi

PR Newswire July 5, 2017

Watch These 7 Huge Put Purchases In Wednesday Trade

Benzinga.com  June 28, 2017

Wall Street's M&A Chatter From June 21: Staples-Sycamore Partners, Diageo-Casamigos, Bristol-Myers, Acadia Pharma

Benzinga.com  June 22, 2017

AstraZeneca Presents New Data Underpinning Safety Profile and Real-World CV Outcomes of Farxiga at ADA 2017

Business Wire June 12, 2017

AstraZeneca to Present Scientific Advances in Cardiovascular and Metabolic Diseases at 2017 ADA Scientific Sessions

Business Wire June 8, 2017

AstraZeneca Presents Tagrisso® (osimertinib) Data in Patients with EGFR T790M-Mutation Positive Lung Cancer and Central Nervous System Metastases

Business Wire June 6, 2017

LYNPARZA™ (olaparib) Significantly Reduces the Risk of Disease Worsening or Death in Patients with BRCA-Mutated Metastatic Breast Cancer

Business Wire June 4, 2017

Drug Makers Stocks on Investors' Radar -- AstraZeneca, Bristol-Myers Squibb, Eli Lilly, and Sanofi

PR Newswire June 1, 2017

Tracking The Busy June PDUFA Calendar

Benzinga.com  May 30, 2017

AstraZeneca Delivers New Data on Expanding Portfolio of Cancer Medicines at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

Business Wire May 26, 2017

AstraZeneca Initiates Voluntary Nationwide Recall of One Lot of BRILINTA 90mg Professional Sample Bottles Due to Report of Another Medicine in One Bottle from That Lot

Business Wire May 25, 2017